Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-04-13 2020-04-13
Drug Identification Number 02483890 02483890
Brand name AZITHROMYCIN FOR INJECTION USP AZITHROMYCIN FOR INJECTION USP
Common or Proper name AZITHROMYCIN FOR INJECTION USP AZITHROMYCIN FOR INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients AZITHROMYCIN AZITHROMYCIN
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS 10 VIALS
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date
Actual start date 2020-03-30 2020-03-30
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments Product is available at McKesson at 100% allocation. Covering Pfizer for Ontario and Alberta. Product is available at McKesson at 100% allocation. Covering Pfizer for Ontario and Alberta.
Health Canada comments